We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$556M
AUM Growth
+$28.1M
Cap. Flow
-$40.2M
Cap. Flow %
-7.23%
Top 10 Hldgs %
17.22%
Holding
230
New
38
Increased
44
Reduced
92
Closed
35

Top Buys

Rank Stock Value
1
TBBK icon
The Bancorp
TBBK
+$6.97M
2
LNW
Light & Wonder
LNW
+$6.69M
3
ELF icon
e.l.f. Beauty
ELF
+$4.06M
4
CNMD icon
CONMED
CNMD
+$4.04M
5
ESE icon
ESCO Technologies
ESE
+$4.04M

Top Sells

Rank Stock Value
1
KNSL icon
Kinsale Capital Group
KNSL
+$11.6M
2
HQY icon
HealthEquity
HQY
+$6.56M
3
ALE
Allete
ALE
+$4.77M
4
HGV icon
Hilton Grand Vacations
HGV
+$4.72M
5
IMGN
Immunogen Inc
IMGN
+$4.51M

Sector Composition

Rank Sector Weight
1 Financials 17.18%
2 Healthcare 16.22%
3 Technology 15.16%
4 Industrials 13.7%
5 Consumer Discretionary 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
101
Regeneron Pharmaceuticals
REGN
$80.8B
$1.75M 0.31%
1,993
-55
-3% -$45.3K
ARWR icon
102
Arrowhead Research
ARWR
$12.4B
$1.66M 0.3%
54,094
-5,575
-9% -$148K
BBY icon
103
Best Buy
BBY
$17.3B
$1.62M 0.29%
20,661
– –
WFG icon
104
West Fraser Timber
WFG
$5.65B
$1.6M 0.29%
18,600
– –
DFS
105
DELISTED
Discover Financial Services
DFS
$1.56M 0.28%
13,923
– –
ABBV icon
106
AbbVie
ABBV
$435B
$1.48M 0.27%
9,526
-112
-1% -$16.3K
EXTR icon
107
Extreme Networks
EXTR
$3.15B
$1.47M 0.26%
83,226
-8,875
-10% -$168K
ALKS icon
108
Alkermes
ALKS
$8.25B
$1.46M 0.26%
52,570
+12,496
+31% +$325K
PTGX icon
109
Protagonist Therapeutics
PTGX
$9.44B
$1.43M 0.26%
62,327
-6,641
-10% -$116K
MSFT icon
110
Microsoft
MSFT
$3.71T
$1.37M 0.25%
4,375
+1,226
+39% +$436K
OC icon
111
Owens Corning
OC
$12.4B
$1.36M 0.25%
9,192
– –
TROW icon
112
T. Rowe Price
TROW
$24.3B
$1.28M 0.23%
11,901
– –
AB icon
113
AllianceBernstein
AB
$3.47B
$1.2M 0.22%
38,559
– –
RCKT icon
114
Rocket Pharmaceuticals
RCKT
$394M
$1.09M 0.2%
36,311
-21,716
-37% -$479K
LLY icon
115
Eli Lilly
LLY
$1.06T
$1.03M 0.18%
1,763
-122
-6% -$71.2K
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$126B
$953K 0.17%
2,341
-52
-2% -$19.2K
BIIB icon
117
Biogen
BIIB
$30.7B
$934K 0.17%
3,610
+1,080
+43% +$265K
KRTX
118
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$934K 0.17%
2,951
+739
+33% +$144K
AMGN icon
119
Amgen
AMGN
$222B
$923K 0.17%
3,203
+4
+0.1% +$1.09K
MRK icon
120
Merck
MRK
$318B
$838K 0.15%
7,689
-495
-6% -$51.4K
NVDA icon
121
NVIDIA
NVDA
$5.42T
$771K 0.14%
15,570
– –
SRPT icon
122
Sarepta Therapeutics
SRPT
$1.77B
$690K 0.12%
7,156
-71
-1% -$6.81K
BMRN icon
123
BioMarin Pharmaceuticals
BMRN
$12.4B
$680K 0.12%
7,049
+1,392
+25% +$123K
AMZN icon
124
Amazon
AMZN
$2.96T
$656K 0.12%
4,319
+1,045
+32% +$146K
NBIX icon
125
Neurocrine Biosciences
NBIX
$16.6B
$641K 0.12%
4,863
– –
3 4
5
6 7

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Moody Aldrich Partners held 230 positions worth $556M, up 5.3% from $528M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Moody Aldrich Partners withdrew a net $40.2M in Q4 2023, closing 35 positions and reducing 92 holdings. Its most notable exit was HealthEquity, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Moody Aldrich Partners opened a new position in The Bancorp worth $7.18M.

  • Moody Aldrich Partners's largest Q4 2023 buy was The Bancorp: 186,299 shares worth $7.18M.
  • Moody Aldrich Partners added most to Leonardo DRS in Q4 2023, an estimated $3.28M increase.
  • Moody Aldrich Partners's biggest Q4 2023 reduction was Kinsale Capital Group, cutting an estimated $11.6M.
  • Moody Aldrich Partners fully exited HealthEquity in Q4 2023, selling an estimated $6.56M.
  • Moody Aldrich Partners's ten largest holdings make up 17% of its $556M portfolio in Q4 2023.
  • Moody Aldrich Partners opened 38 new positions and closed 35 in Q4 2023.
  • Moody Aldrich Partners's portfolio value rose 5.3% quarter-over-quarter to $556M.

Based on Moody Aldrich Partners's 13F filing for Q4 2023, filed 26 Jan 2024.